AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Price Up 2.2% – Here’s Why

Posted by John Perry on Nov 29th, 2025

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report)’s share price shot up 2.2% on Wednesday . The company traded as high as $18.48 and last traded at $18.45. 3,248 shares were traded during mid-day trading, a decline of 76% from the average session volume of 13,539 shares. The stock had previously closed at $18.06.

AdvisorShares Psychedelics ETF Price Performance

The business’s 50-day simple moving average is $19.05 and its two-hundred day simple moving average is $16.65.

AdvisorShares Psychedelics ETF Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 29th. Investors of record on Monday, September 22nd were issued a dividend of $0.0201 per share. The ex-dividend date of this dividend was Monday, September 22nd. This represents a $0.08 annualized dividend and a dividend yield of 0.4%.

Hedge Funds Weigh In On AdvisorShares Psychedelics ETF

An institutional investor recently bought a new position in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. purchased a new position in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned about 2.50% of AdvisorShares Psychedelics ETF at the end of the most recent quarter.

About AdvisorShares Psychedelics ETF

(Get Free Report)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.